Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility

EAST RUTHERFORD, N.J., Aug. 11, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and

Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion

Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland

Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics'

LOTTE BIOLOGICS to Kick off their CDMO Business Campaign at 'BIO International Convention 2023'

Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and

Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise